Action Point Financial Planning’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
Other funds holding IOVA
Action Point Financial Planning's IOVA Position: Q3 2026 in Review
Action Point Financial Planning sold out of Iovance Biotherapeutics (IOVA) in Q3 2026, closing a stake of 1,926 shares — an estimated $8.01K sold.
Action Point Financial Planning first reported a position in IOVA in Q2 2026 and held it in 1 quarter. The position peaked at $8.01K in Q2 2026. 335 funds tracked by Wall St. Rank hold IOVA as of Q3 2026.
- Action Point Financial Planning reported no remaining Iovance Biotherapeutics position as of Q3 2026 after selling out during the quarter.
- Action Point Financial Planning sold 1,926 Iovance Biotherapeutics shares in Q3 2026, an estimated $8.01K.
- Action Point Financial Planning first reported a position in Iovance Biotherapeutics in Q2 2026 and held it in 1 quarter.
- Action Point Financial Planning's Iovance Biotherapeutics position peaked at $8.01K in Q2 2026.
- 335 funds tracked by Wall St. Rank held Iovance Biotherapeutics as of Q3 2026.
Based on Action Point Financial Planning's 13F filing for Q3 2026, filed 13 Nov 2026.